IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v4y2013i1d10.1038_ncomms2550.html
   My bibliography  Save this article

An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells

Author

Listed:
  • Antonio Filareto

    (Lillehei Heart Institute, University of Minnesota)

  • Sarah Parker

    (Lillehei Heart Institute, University of Minnesota)

  • Radbod Darabi

    (Lillehei Heart Institute, University of Minnesota)

  • Luciene Borges

    (Lillehei Heart Institute, University of Minnesota)

  • Michelina Iacovino

    (Lillehei Heart Institute, University of Minnesota)

  • Tory Schaaf

    (Lillehei Heart Institute, University of Minnesota)

  • Timothy Mayerhofer

    (Lillehei Heart Institute, University of Minnesota)

  • Jeffrey S. Chamberlain

    (University of Washington School of Medicine, K243b HSB, Box 357720, 1959 N.E. Pacific Street, Seattle, Washington 98195-7720, USA)

  • James M. Ervasti

    (Molecular Biology and Biophysics, University of Minnesota)

  • R. Scott McIvor

    (Cell Biology and Development, University of Minnesota)

  • Michael Kyba

    (Lillehei Heart Institute, University of Minnesota)

  • Rita C. R. Perlingeiro

    (Lillehei Heart Institute, University of Minnesota)

Abstract

Duchenne muscular dystrophy is a progressive and incurable neuromuscular disease caused by genetic and biochemical defects of the dystrophin–glycoprotein complex. Here we show the regenerative potential of myogenic progenitors derived from corrected dystrophic induced pluripotent stem cells generated from fibroblasts of mice lacking both dystrophin and utrophin. We correct the phenotype of dystrophic induced pluripotent stem cells using a Sleeping Beauty transposon system carrying the micro-utrophin gene, differentiate these cells into skeletal muscle progenitors and transplant them back into dystrophic mice. Engrafted muscles displayed large numbers of micro-utrophin-positive myofibers, with biochemically restored dystrophin–glycoprotein complex and improved contractile strength. The transplanted cells seed the satellite cell compartment, responded properly to injury and exhibit neuromuscular synapses. We also detect muscle engraftment after systemic delivery of these corrected progenitors. These results represent an important advance towards the future treatment of muscular dystrophies using genetically corrected autologous induced pluripotent stem cells.

Suggested Citation

  • Antonio Filareto & Sarah Parker & Radbod Darabi & Luciene Borges & Michelina Iacovino & Tory Schaaf & Timothy Mayerhofer & Jeffrey S. Chamberlain & James M. Ervasti & R. Scott McIvor & Michael Kyba & , 2013. "An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells," Nature Communications, Nature, vol. 4(1), pages 1-9, June.
    • Handle: RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms2550
    DOI: 10.1038/ncomms2550
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms2550
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/ncomms2550?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Zhongyu Zhang & Zhengde Zhao & Xiuyi Huang & Lifang Zhou & Xin Jiang & Haoliang Wu & Chenshu Liu & Kan Huang & Jielu Wen & Yunchong Liu & Michelle C. Miller & Zihan Zhao & Zhen He & Yuxin Wang & Siyu , 2025. "Galectin-3-integrin α5β1 phase separation disrupted by advanced glycation end-products impairs diabetic wound healing in rodents," Nature Communications, Nature, vol. 16(1), pages 1-23, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms2550. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.